Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The aim of the study is to test the safety and efficacy of BL-8040 (a CXCR4 antagonist) in improving the response to imatinib in CML patients not achieving an optimal response with imatinib alone.
Critère d'inclusion
- Chronic myeloid leukemia